Effect of carboxymethyl-chitin-glucan on cyclophosphamide induced mutagenicity.
The effect of high molecular carboxymethyl-chitin-glucan (CMCG), administered either intraperitoneally, intravenously or orally prior to cyclophosphamide injection, on the frequency of micronucleated reticulocytes was evaluated in peripheral blood of female ICR mice. Both intraperitoneal and intravenous administration of CMCG decreased the clastogenic effect of cyclophosphamide. The protective effect of CMCG was concentration dependent, with a higher decrease achieved by 100 mg/kg than by 50 mg/kg body weight. On the other hand, not even five peroral pretreatments with CMCG in the dose of 200 mg/kg body weight during the week prior to simultaneous administration of CMCG and cyclophosphamide induced a decrease of micronucleated reticulocytes in peripheral blood. It is therefore conceivable that CMCG failed to pass through the gastrointestinal tract, probably due to its high molecular weight. The antimutagenic effect of CMCG against cyclophosphamide was manifested by its intraperitoneal and intravenous administration to female ICR mice.
Chorvatovicová
D
D
Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava.
Sandula
J
J
D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D002686:Chitin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology*; D004333:Drug Administration Routes; D005260:Female; D005936:Glucans / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008813:Mice, Inbred ICR; D016296:Mutagenesis; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology*; D012156:Reticulocytes / Q000473:pathology
D016587:Antimutagenic Agents; D005936:Glucans; D009153:Mutagens; C091649:carboxymethyl-chitin-glucan; D002686:Chitin; D003520:Cyclophosphamide